Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

Name: Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
License: Public Domain

Novartis Pharmaceuticals

ClinicalTrials.gov · Datasets · License: Public Domain

diabetic retinopathy, macular oedema

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 253152
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.